Older adults with adenoma at prior colonoscopy more likely to experience CRC but risk exceeded by competing risks for non-CRC death.

No increase seen in incidence of major bleeding, adverse events, or serious adverse events compared with placebo.

Supported by the phase 3 ALLEGORY trial, the application moves obinutuzumab closer to becoming a new standard for patients with active, autoantibody-positive SLE.

Psychedelic drugs could soon play a larger role in mental health care. Over the weekend, President Donald Trump signed an executive order aimed at boosting fede ...

Phase 3 KEYNOTE-B15 data demonstrate that perioperative enfortumab vedotin and pembrolizumab significantly improve EFS, OS, and pCR compared with standard chemotherapy.

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.

Topline data for the once-daily PKR activator etavopivat demonstrate a 27% reduction in vaso-occlusive crises and a robust hematologic response in patients with SCD.

Based on positive phase 3 trial results, a New Drug Application will be submitted to the Food and Drug Administration for daraxonrasib.

Human-generated notes received higher overall modified Physician Documentation Quality Instrument scores than AI-generated notes across all 5 clinical cases. HealthDay News — Notes generated by ...

Recommendations say clinicians should use biennial mammography for breast cancer screening in asymptomatic, average-risk women aged 50 to 74 years ...

Sixty-eight percent of studies exceeded benchmark of about 25% total weight loss attributable to reduction in muscle-based indices.